1. Catalog
  2. Psychopharmacology Management of Early Psychosis D ...
Psychopharmacology Management of Early Psychosis During the COVID-19 Pandemic
(1)
Image For Activity Cover
Create Account
Availability
On-Demand
Expires on May 03, 2024
Credit Offered
1 CME Credit
1 Psych CE Credit
1 SW CE Credit
1 COP Credit

This session will focus on psychopharmacology management of early psychosis in the COVID-19 era. The changes brought by the pandemic almost overnight had a profound effect on society and psychiatry, including in early psychosis care. We will begin with an overview of the impacts of the COVID-19 pandemic and mitigation efforts on society in general. We will review the potential for elevated psychopathology in the general population and emerging data in this regard. Topics include anxiety, depression, substance use, and suicide and these are all relevant to the early psychosis population as well as other segments of society. We will also review how COVID-19 infection alters pharmacokinetics and pharmacodynamics in the body and what these changes might mean for psychopharmacology management in people with psychotic disorders. We will discuss the possibility of early psychosis patients developing COVID-disease – this has been a relatively minor problem thus far.

Format

Recorded webinar, non-interactive, self-paced distance learning activity with post-test.

This presentation was recorded on November 12, 2020 at the virtual conference, Third National Conference on Advancing Early Psychosis Care in the United States: Addressing Inequities - Race, Culture, and COVID. 

Learning Objectives

  • Describe COVID-related changes in physiology and psychopathology that may be seen in people with early psychosis.
  • Outline principles for managing psychopharmacology in early psychosis.
  • Describe potential access and health disparities impacting people with early psychosis in the COVID era.

Outline

  • COVID-related changes in those with first episode psychosis
  • Psychopharmacology and first episode psychosis
  • Access and health disparities in the COVID era

Target Audience

Psychologists, Social Workers, and Other Mental Health Professionals

Instructional Level

Advanced

Estimate Time to Complete

Estimated Duration: 1.0 hour
Program Start Date: May 3, 2021 
Program End Date: May 3, 2024

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™, CE credit for psychologists, CE credit for social workers, or a certificate of participation may do so by completing all sections of the course, including viewing the full video (≥60 minutes) and submitting an evaluation. A multiple-choice quiz is provided based on the content. A passing score of 75% must be achieved. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians), CE certificate (psychologists), CE certificate (social workers), or certificate of participation (other disciplines) showing the completion date and hours/credits earned.

Continuing Education Credit

Physicians

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologists

The American Psychiatric Association is approved by the American Psychological Association to sponsor continuing education for psychologists. American Psychiatric Association maintains responsibility for this program and its content.

Social Workers 

American Psychiatric Association, provider #1743, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. American Psychiatric Association maintains responsibility for this course. ACE provider approval period: 05/18/2020 – 05/18/2021 and 05/18/2021-05/18/2024. Social workers completing this course receive 1.0 (clinical) continuing education credits.

Continuing education requirements vary from state to state. Many state boards grant reciprocity with national accrediting organizations and other state boards. It is the responsibility of each professional to understand the requirements for license renewal or check with the state or national licensing board and/or professional organization to become more familiar with their policies for acceptable continuing education credit. Social workers and Psychologists should contact their regulatory board to determine course approval.

Faculty and Planner Disclosures

Instructors

  • Dost Öngür, M.D., Ph.D., is the William P. and Henry B. Test Professor of Psychiatry at Harvard Medical School and Chief of Psychotic Disorders Division at McLean Hospital. His research focuses on clinical trajectories of people with early psychosis as well as neuroimaging studies of brain abnormalities in these conditions. He launched McLean OnTrack, a subspecialty service for early psychosis in 2012. He has received awards for his teaching and mentoring. He is the Editor in Chief of JAMA Psychiatry and a fellow of the APA and ACNP. Reports no financial relationships with commercial interests.
  • Ann Hackman, M.D., is the Division Director for Community Psychiatry at the University of Maryland School of Medicine. Her career has focused on treatment of people living with schizophrenia. She has spent more than 25 years working on an Assertive Community Treatment team and for the past decade has been the lead psychiatrist on a RAISE Connection model EIP program. Dr. Hackman has received awards for medical student and resident teaching. She serves on the executive committee of the American Association for Community Psychiatry. Reports no financial relationships with commercial interests.

Program Planners

  • Steven Adelsheim, M.D. Reports no financial relationships with commercial interests.
  • Catherine Adams, L.M.S.W., A.C.S.W., C.A.A.D.C. Reports no financial relationships with commercial interests.
  • Susan T. Azrin, Ph.D.  Reports no financial relationships with commercial interests.
  • Iruma Bello, Ph.D.  Reports no financial relationships with commercial interests.
  • Gary Michael Blau, M.S., Ph.D.  Reports no financial relationships with commercial interests.
  • Teri S. Brister, Ph.D., L.P.C.  Reports no financial relationships with commercial interests.
  • Nybelle An-Vi Caruso, B.S.  Reports no financial relationships with commercial interests.
  • Amy N. Cohen, Ph.D.  Reports no financial relationships with commercial interests.
  • Robert O. Cotes, M.D.  Dr. Cotes discloses the following relationships: Consultant: Saladax Biomedical, American Psychiatric Association Grant/Research: Ostuka, Lundbeck, Roche, Alkermes
  • Judith Dauberman, M.A., Ph.D.  Reports no financial relationships with commercial interests.
  • Steven P. Dettwyler, Ph.D.  Reports no financial relationships with commercial interests.
  • Lisa B. Dixon, M.D., M.P.H.  Reports no financial relationships with commercial interests.
  • Melissa Edmondson Smith, Ph.D.  Reports no financial relationships with commercial interests.
  • Chantel Garrett. Ms. Garrett discloses the following relationships: Stock: Invitae, stockholder Livongo, stockholder Color, private equity holder Consultant: Maine Health Northwell Health One Mind Grant/Research: One Mind National Institute of Health
  • Tristan Gorrindo, M.D.  Reports no financial relationships with commercial interests.
  • Kate Hardy, ClinPsych.D.  Ms. Hardy discloses the following relationships: Consultant: SME for Click Therapeutics
  • Robert K. Heinssen, Ph.D., A.B.P.P. Reports no financial relationships with commercial interests.
  • Brian Hepburn, M.D.  Reports no financial relationships with commercial interests.
  • Patrick Kaufmann, B.S.  Reports no financial relationships with commercial interests.
  • Sherin Khan, L.C.S.W. Reports no financial relationships with commercial interests.
  • Steven R. Lopez, Ph.D. Reports no financial relationships with commercial interests.
  • Ted Lutterman.  Reports no financial relationships with commercial interests.
  • Tushita Mayanil, M.D.  Reports no financial relationships with commercial interests.
  • Ryan Melton, Ph.D.  Reports no financial relationships with commercial interests.
  • Oladunni Oluwoye , Ph.D.  Reports no financial relationships with commercial interests.
  • Abram Rosenblatt, Ph.D.  Reports no financial relationships with commercial interests.
  • David L. Shern, Ph.D.  Dr. Shern discloses the following relationships: Grant/Research: Through my employment at NASMHPD, I co-chair the dissemination function of the Early Psychosis Intervention network as part of the national data coordinating center at Westat. Westat was awarded the coordinating center grant by NIMH Other: serve on the Board of Livanta

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.

Technical Requirements

This internet-based CME activity is best experienced using any of the following:

  • The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
  • Internet Explorer 11+

This website requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be:  Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
  • Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
  • Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content

For assistance: Contact educme@psych.org for questions about this activity | Contact SMIadviserhelp@psych.org for technical assistance

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Powered By